Neuronetics (STIM) Income from Non-Controlling Interests (2025 - 2026)
Neuronetics' (STIM) quarterly Income from Non-Controlling Interests came in at $10000.0 in Q1 2026, up 171.43% year-on-year from $3684.2 in Q1 2025, and up 120.83% on a QoQ basis from -$48000.0 in Q4 2025.
Neuronetics (STIM) Income from Non-Controlling Interests (2025 - 2026) Analysis & Trends
Neuronetics (STIM) has 2 years of Income from Non-Controlling Interests data on file, last reported at $10000.0 in Q1 2026.
- On a quarterly basis, Income from Non-Controlling Interests rose 171.43% year-over-year to $10000.0 in Q1 2026; TTM through Mar 2026 was -$113000.0, a N/A change from a year earlier, with the FY2025 full-year figure at -$137000.0, down 621.05% from the prior year.
- Income from Non-Controlling Interests for Q1 2026 stood at $10000.0, up from -$48000.0 in the prior quarter.
- Over the last five years, Income from Non-Controlling Interests for STIM reached as high as $281000.0 in Q2 2025 and fell as low as -$356000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.91 Bn | 176.62 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.87 Bn | 125.99 Bn | 3.81 Bn | - |
| 3 | Medtronic | 108.72 Bn | 99.50 Bn | 6.41 Bn | 16.00 Mn |
| 4 | Boston Scientific | 68.46 Bn | 67.01 Bn | 3.61 Bn | -2.00 Mn |
| 5 | Edwards Lifesciences | 48.53 Bn | 44.85 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.37 Bn | 27.25 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 28.34 Bn | 26.06 Bn | 1.98 Bn | 22.00 Mn |
| 8 | Smith & Nephew | 26.91 Bn | 26.33 Bn | - | - |
| 9 | Koninklijke Philips | 25.47 Bn | 22.34 Bn | 2.07 Bn | -5.85 Mn |
| 10 | Neuronetics | 120.39 Mn | 114.38 Mn | 16.15 Mn | 10,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10,000.00 |
| Dec 31, 2025 | -48,000.00 |
| Sep 30, 2025 | -356,000.00 |
| Jun 30, 2025 | 281,000.00 |
| Mar 31, 2025 | -14,000.00 |